Jinhui Dou

773 total citations
18 papers, 573 citations indexed

About

Jinhui Dou is a scholar working on Molecular Biology, Complementary and alternative medicine and Biochemistry. According to data from OpenAlex, Jinhui Dou has authored 18 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Complementary and alternative medicine and 4 papers in Biochemistry. Recurrent topics in Jinhui Dou's work include Phytochemical compounds biological activities (6 papers), Complementary and Alternative Medicine Studies (4 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). Jinhui Dou is often cited by papers focused on Phytochemical compounds biological activities (6 papers), Complementary and Alternative Medicine Studies (4 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). Jinhui Dou collaborates with scholars based in United States, China and Taiwan. Jinhui Dou's co-authors include James D. McChesney, Lester A. Mitscher, Delbert M. Shankel, Michel J. Jung, Segaran P. Pillai, Kuei‐Meng Wu, Wenjie Wang, Shouyan Wu, Robert D. Sindelar and Larry Walker and has published in prestigious journals such as Nature Biotechnology, Journal of Ethnopharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Jinhui Dou

18 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinhui Dou United States 12 226 132 127 114 114 18 573
Jong Moon Hur South Korea 12 221 1.0× 87 0.7× 120 0.9× 50 0.4× 106 0.9× 24 491
Chiu‐Li Kao Taiwan 7 240 1.1× 130 1.0× 87 0.7× 45 0.4× 51 0.4× 14 560
Iqra Sarfraz Pakistan 14 398 1.8× 91 0.7× 130 1.0× 72 0.6× 88 0.8× 23 816
Aristatile Balakrishnan Saudi Arabia 14 164 0.7× 105 0.8× 108 0.9× 41 0.4× 65 0.6× 24 555
P. Sachdanandam India 14 176 0.8× 100 0.8× 176 1.4× 30 0.3× 210 1.8× 33 610
Hye-Kyung Na South Korea 9 261 1.2× 145 1.1× 111 0.9× 57 0.5× 52 0.5× 10 545
Archana Sengupta India 13 158 0.7× 111 0.8× 186 1.5× 59 0.5× 82 0.7× 20 495
Wing Ping Fong Hong Kong 10 217 1.0× 68 0.5× 74 0.6× 179 1.6× 49 0.4× 13 654
Angkana Herunsalee Thailand 13 192 0.8× 237 1.8× 167 1.3× 31 0.3× 145 1.3× 19 702
Salah A. Ghareib Saudi Arabia 15 159 0.7× 112 0.8× 211 1.7× 42 0.4× 93 0.8× 25 613

Countries citing papers authored by Jinhui Dou

Since Specialization
Citations

This map shows the geographic impact of Jinhui Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinhui Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinhui Dou more than expected).

Fields of papers citing papers by Jinhui Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinhui Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinhui Dou. The network helps show where Jinhui Dou may publish in the future.

Co-authorship network of co-authors of Jinhui Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Jinhui Dou. A scholar is included among the top collaborators of Jinhui Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinhui Dou. Jinhui Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
He, Gaohong, et al.. (2025). Carboxymethyl chitosan modification via EDC/NHS-mediated amidation for performance improvement on blood-contacting biomedical membranes. International Journal of Biological Macromolecules. 319(Pt 2). 145496–145496. 1 indexed citations
2.
Dou, Daolong, et al.. (2024). Global regulatory considerations and practices for tumorigenicity evaluation of cell-based therapy. Regulatory Toxicology and Pharmacology. 156. 105769–105769. 1 indexed citations
3.
Dou, Jinhui & Pamela J. Weathers. (2022). Specialty molecules from plants and in vitro cultures as new drugs: regulatory considerations from flask to patient. Plant Cell Tissue and Organ Culture (PCTOC). 149(1-2). 105–111. 4 indexed citations
4.
Wu, Shouyan, et al.. (2020). Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury. Acta Pharmacologica Sinica. 42(1). 18–26. 60 indexed citations
5.
White, Jeffrey D., Libin Jia, Roy S. Wu, et al.. (2016). Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer. Journal of Global Oncology. 3(6). 814–822. 2 indexed citations
6.
Fan, Tai‐Ping, Daryl D. Rees, He Sun, et al.. (2012). Future development of global regulations of Chinese herbal products. Journal of Ethnopharmacology. 140(3). 568–586. 83 indexed citations
8.
Wu, Kuei‐Meng, et al.. (2009). Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.A.. Regulatory Toxicology and Pharmacology. 56(1). 1–3. 20 indexed citations
9.
Dou, Jinhui, et al.. (2008). New therapies from old medicines. Nature Biotechnology. 26(10). 1077–1083. 74 indexed citations
10.
Wu, Kuei‐Meng, James G. Farrelly, Debra Birnkrant, et al.. (2004). Regulatory Toxicology Perspectives on the Development of Botanical Drug Products in the United States. American Journal of Therapeutics. 11(3). 213–217. 18 indexed citations
11.
Mata‐Greenwood, Eugenia, John F. Daeuble, Paul A. Grieco, et al.. (2001). Novel Esters of Glaucarubolone as Inducers of Terminal Differentiation of Promyelocytic HL-60 Cells and Inhibitors of 7,12-Dimethylbenz[a]anthracene-Induced Preneoplastic Lesion Formation in Mouse Mammary Organ Culture. Journal of Natural Products. 64(12). 1509–1513. 21 indexed citations
12.
Dayan, Franck E., Susan B. Watson, Juan C. G. Galindo, et al.. (1999). Phytotoxicity of Quassinoids: Physiological Responses and Structural Requirements. Pesticide Biochemistry and Physiology. 65(1). 15–24. 43 indexed citations
13.
Mitscher, Lester A., et al.. (1997). Chemoprotection: A review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Medicinal Research Reviews. 17(4). 327–365. 138 indexed citations
14.
McChesney, James D., et al.. (1997). Tirucallane-type triterpenoids: nmr and X-ray diffraction analyses of 24-epi-piscidinol A and piscidinol A. Journal of Chemical Crystallography. 27(5). 283–290. 38 indexed citations
16.
Dou, Jinhui, Ikhlas A. Khan, James D. McChesney, & Charles L. Burandt. (1996). Qualitative and Quantitative High Performance Liquid Chromatographic Analysis of Quassinoids in Simaroubaceae Plants. Phytochemical Analysis. 7(4). 192–200. 9 indexed citations
17.
Dou, Jinhui, et al.. (1996). A New Quassinoid from Crude Quassin-extract of Quassia amara. International Journal of Pharmacognosy. 34(5). 349–354. 14 indexed citations
18.
Dou, Jinhui, et al.. (1996). A New Quassinoid from Castela texana. Journal of Natural Products. 59(1). 73–76. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026